Genzyme plots big growth at Framingham plant

Genzyme (NASDAQ: GENZ) isn't letting a little manufacturing crisis get in the way of its ambitious long-term growth plans. The big biotech outfit has blueprinted a massive 757,000-square-foot expansion at its Framingham, MA, facility. Report